Parkway Life REIT (SGX: C2PU): Defensive Growth?

Parkway Life REIT (PLife REIT) continues to anchor the "RealisedGains" defensive portfolio with its high-quality healthcare asset base across Singapore, Japan, and France. The Group reported a resilient 8.1% revenue growth for 1H 2025, driven by its maiden acquisition of 11 nursing homes in France and additional recycling into Japan. With 97% of its debt on fixed rates, PLife is well-hedged against global interest rate volatility.

💡 Growth Drivers & "So What?"

• Singapore Bed Supply: The renewal of master-leases for its three private hospitals (MEH, Gleneagles, Parkway East) through 2042 provides 20 years of earnings visibility with built-in rental escalators.

• European Diversification: The H2 2024 entry into France allows PLife to capture the aging population tailwind in a deep-fundamentals European market.

• Asset Recycling: Ongoing recycling of older Japan assets into yield-accretive facilities continues to sustain dividend growth.

💰 Dividend & Distribution History

PLife REIT has maintained its status as a dividend champion with consistent distribution growth.

• 1H 2025 Interim DPU: 7.65 cents (Paid Sept 2025), a 1.5% increase from 1H 2024.

• Payout Trend: The annualised DPU has grown to 15.30 cents, reflecting a 3.7% yield based on recent prices.

🚩 Potential Risks

• Currency Exposure: Depreciation of the JPY vs SGD can impact translated earnings, though hedged via forward contracts.

• Refinancing Costs: While 97% fixed, future debt renewals will face higher base rates.

🏁 Market Sentiment: Bullis 🟢

• Target Price: S$4.60 – S$4.82 (Consensus)

• Current Price: S$4.13 (As of Jan 23, 2026)

• Why? PLife REIT trades at a significant premium to its sector average due to its defensive moat. With 20-year leases and healthcare stability, it remains a rare "core" jewel for income seekers.